<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Endocrine Care</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Christian</forename><surname>Von Loeffelholz</surname></persName>
							<email>christian.von_loeffelholz@med.uni-jena.de</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Clinical Nutrition</orgName>
								<orgName type="institution">German Institute of Human Nutrition Potsdam-Rehbruecke</orgName>
								<address>
									<settlement>Nuthetal</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Integrated Research and Treatment Center</orgName>
								<orgName type="department" key="dep2">Center for Sepsis Control and Care (CSCC)</orgName>
								<orgName type="institution">Jena University Hospital</orgName>
								<address>
									<settlement>Jena</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Department of Endocrinology, Diabetes, and Nutrition</orgName>
								<orgName type="institution">Charité -Universitätsmedizin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff9">
								<orgName type="department">Institute of Epidemiology II</orgName>
								<orgName type="institution">Helmholtz Zentrum Muenchen</orgName>
							</affiliation>
							<affiliation key="aff10">
								<orgName type="institution">German Research Center for Environmental Health</orgName>
								<address>
									<settlement>Neuherberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andreas</forename><forename type="middle">F H</forename><surname>Pfeiffer</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Clinical Nutrition</orgName>
								<orgName type="institution">German Institute of Human Nutrition Potsdam-Rehbruecke</orgName>
								<address>
									<settlement>Nuthetal</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Department of Endocrinology, Diabetes, and Nutrition</orgName>
								<orgName type="institution">Charité -Universitätsmedizin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">Department of General</orgName>
								<orgName type="institution" key="instit1">Visceral-, Vascular-and Paediatric Surgery</orgName>
								<orgName type="institution" key="instit2">University Hospital of Wuerzburg</orgName>
								<address>
									<settlement>Wuerzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Johan</forename><forename type="middle">F</forename><surname>Lock</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Section of Metabolic and Vascular Medicine</orgName>
								<orgName type="institution">Medical Clinic III</orgName>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="institution">University Hospital Carl Gustav Carus</orgName>
								<address>
									<settlement>Dresden</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Steffi</forename><surname>Lieske</surname></persName>
							<affiliation key="aff7">
								<orgName type="laboratory">Research Unit of Molecular Epidemiology</orgName>
								<orgName type="institution" key="instit1">Helmholtz Zentrum Muenchen</orgName>
								<orgName type="institution" key="instit2">German Research Center for Environmental Health</orgName>
								<address>
									<settlement>Neuherberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Stephanie</forename><surname>Döcke</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Clinical Nutrition</orgName>
								<orgName type="institution">German Institute of Human Nutrition Potsdam-Rehbruecke</orgName>
								<address>
									<settlement>Nuthetal</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Veronica</forename><surname>Murahovschi</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Clinical Nutrition</orgName>
								<orgName type="institution">German Institute of Human Nutrition Potsdam-Rehbruecke</orgName>
								<address>
									<settlement>Nuthetal</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jennifer</forename><surname>Kriebel</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Endocrinology, Diabetes, and Nutrition</orgName>
								<orgName type="institution">Charité -Universitätsmedizin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff8">
								<orgName type="department">German Center for Diabetes Research (DZD)</orgName>
								<address>
									<settlement>Neuherberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff9">
								<orgName type="department">Institute of Epidemiology II</orgName>
								<orgName type="institution">Helmholtz Zentrum Muenchen</orgName>
							</affiliation>
							<affiliation key="aff10">
								<orgName type="institution">German Research Center for Environmental Health</orgName>
								<address>
									<settlement>Neuherberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Tonia</forename><surname>De Las Heras Gala</surname></persName>
							<affiliation key="aff11">
								<orgName type="department">Institute of Epidemiolo-gy II</orgName>
								<orgName type="laboratory">Research Unit of Diabetes Epidemiology</orgName>
								<orgName type="institution" key="instit1">Helmholtz Zentrum München</orgName>
								<orgName type="institution" key="instit2">German Research Center for Environmental Health</orgName>
								<address>
									<settlement>Neuherberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Harald</forename><surname>Grallert</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Endocrinology, Diabetes, and Nutrition</orgName>
								<orgName type="institution">Charité -Universitätsmedizin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff8">
								<orgName type="department">German Center for Diabetes Research (DZD)</orgName>
								<address>
									<settlement>Neuherberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff9">
								<orgName type="department">Institute of Epidemiology II</orgName>
								<orgName type="institution">Helmholtz Zentrum Muenchen</orgName>
							</affiliation>
							<affiliation key="aff10">
								<orgName type="institution">German Research Center for Environmental Health</orgName>
								<address>
									<settlement>Neuherberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Natalia</forename><surname>Rudovich</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Clinical Nutrition</orgName>
								<orgName type="institution">German Institute of Human Nutrition Potsdam-Rehbruecke</orgName>
								<address>
									<settlement>Nuthetal</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">Department of General</orgName>
								<orgName type="institution" key="instit1">Visceral-, Vascular-and Paediatric Surgery</orgName>
								<orgName type="institution" key="instit2">University Hospital of Wuerzburg</orgName>
								<address>
									<settlement>Wuerzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Martin</forename><surname>Stockmann</surname></persName>
							<affiliation key="aff12">
								<orgName type="department">Department of General, Visceral and Transplantation Surgery</orgName>
								<orgName type="institution">Charité -Universitätsmedizin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Joachim</forename><surname>Spranger</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Department of General</orgName>
								<orgName type="institution" key="instit1">Visceral-, Vascular-and Paediatric Surgery</orgName>
								<orgName type="institution" key="instit2">University Hospital of Wuerzburg</orgName>
								<address>
									<settlement>Wuerzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Gerhard</forename><surname>Jahreis</surname></persName>
							<affiliation key="aff13">
								<orgName type="department">Institute of Nutrition</orgName>
								<orgName type="institution">Friedrich Schiller University</orgName>
								<address>
									<settlement>Jena</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Stefan</forename><forename type="middle">R</forename><surname>Bornstein</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Endocrinology, Diabetes, and Nutrition</orgName>
								<orgName type="institution">Charité -Universitätsmedizin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<orgName type="laboratory">Research Unit of Molecular Epidemiology</orgName>
								<orgName type="institution" key="instit1">Helmholtz Zentrum Muenchen</orgName>
								<orgName type="institution" key="instit2">German Research Center for Environmental Health</orgName>
								<address>
									<settlement>Neuherberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">George</forename><surname>Lau</surname></persName>
							<affiliation key="aff14">
								<orgName type="department">Humanity and Health GI and Liver Centre</orgName>
								<orgName type="institution">University of Hong Kong</orgName>
								<address>
									<settlement>Hong Kong SAR</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Aimin</forename><surname>Xu</surname></persName>
							<affiliation key="aff15">
								<orgName type="department">Department of Pharmacology &amp; Pharmacy</orgName>
								<orgName type="institution">University of Hong Kong</orgName>
								<address>
									<settlement>Hong Kong SAR</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jeanette</forename><surname>Schulz-Menger</surname></persName>
							<affiliation key="aff16">
								<orgName type="department" key="dep1">Department of Cardiology and Nephrology</orgName>
								<orgName type="department" key="dep2">Experimental and Clinical Research Center</orgName>
								<orgName type="laboratory">Working Group on Cardiovascular Magnetic Resonance Imaging</orgName>
								<orgName type="institution" key="instit1">Max-Delbrück-Centrum and Charité-Medical University Berlin</orgName>
								<orgName type="institution" key="instit2">HELIOS Klinikum Berlin-Buch</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Louisa</forename><surname>Exner</surname></persName>
							<affiliation key="aff17">
								<orgName type="department" key="dep1">Institute of Clinical Pharmacology</orgName>
								<orgName type="department" key="dep2">Hannover Medical School</orgName>
								<address>
									<settlement>Hannover</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sven</forename><surname>Haufe</surname></persName>
							<affiliation key="aff17">
								<orgName type="department" key="dep1">Institute of Clinical Pharmacology</orgName>
								<orgName type="department" key="dep2">Hannover Medical School</orgName>
								<address>
									<settlement>Hannover</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jens</forename><surname>Jordan</surname></persName>
							<affiliation key="aff17">
								<orgName type="department" key="dep1">Institute of Clinical Pharmacology</orgName>
								<orgName type="department" key="dep2">Hannover Medical School</orgName>
								<address>
									<settlement>Hannover</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Stefan</forename><surname>Engeli</surname></persName>
							<affiliation key="aff17">
								<orgName type="department" key="dep1">Institute of Clinical Pharmacology</orgName>
								<orgName type="department" key="dep2">Hannover Medical School</orgName>
								<address>
									<settlement>Hannover</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andreas</forename><forename type="middle">L</forename><surname>Birkenfeld</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Endocrinology, Diabetes, and Nutrition</orgName>
								<orgName type="institution">Charité -Universitätsmedizin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<orgName type="laboratory">Research Unit of Molecular Epidemiology</orgName>
								<orgName type="institution" key="instit1">Helmholtz Zentrum Muenchen</orgName>
								<orgName type="institution" key="instit2">German Research Center for Environmental Health</orgName>
								<address>
									<settlement>Neuherberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff18">
								<orgName type="department">Competence Center for Metabolic Vascular Medicine Prof. Hanefeld</orgName>
								<orgName type="institution">GWT-TU</orgName>
								<address>
									<settlement>Dresden, Dresden</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff19">
								<orgName type="department">Section of Diabetes and Nutritional Sciences</orgName>
								<orgName type="institution">King&apos;s College London</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="department">Department of Anaesthesiology and Intensive Care</orgName>
								<orgName type="institution">Jena University Hospital</orgName>
								<address>
									<settlement>Jena</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff20">
								<orgName type="department">Department of Anaesthesiology and Intensive Care</orgName>
								<orgName type="institution">Friedrich Schiller University of Jena Erlanger Allee</orgName>
								<address>
									<postCode>101 07747</postCode>
									<settlement>Jena</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Endocrine Care</title>
					</analytic>
					<monogr>
						<idno type="ISSN">0018-5043</idno>
					</monogr>
					<idno type="MD5">3B4A102CCFA3534A6F71B56B1083DC91</idno>
					<idno type="DOI">10.1055/s-0043-102950</idno>
					<note type="submission">received 20.08.2016 accepted 24.01.2017</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:36+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>diabetes</term>
					<term>fatty acids</term>
					<term>insulin resistance</term>
					<term>fatty liver</term>
					<term>hepatokine</term>
					<term>HDL</term>
					<term>LDL</term>
					<term>triacylglycerides</term>
				</keywords>
			</textClass>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>ceral adipose tissue and associations with circulating fatty acid profile</s></p><p><s>have not yet been investigated.</s><s>Forty subjects were included in a cross-sectional study, 57 in a dietary weight reduction intervention.</s><s>Circulating Angiopoietin-like protein 8/ betatrophin was measured in all subjects.</s><s>Liver and adipose tissue were sampled and plasma fatty acids and tissue Angiopoietin-like protein 8/ betatrophin expression were evaluated in the cross-sectional study.</s><s>In the intervention study oral glucose testing and liver magnetic resonance scanning at baseline and after 6 months were performed.</s><s>Angiopoietin-like protein 8/betatrophin mRNA was increased in visceral compared to subcutaneous adipose tissue (p &lt; 0.001).</s><s>Circulating ANGPTL8/betatrophin correlated with liver steatosis (r = 0.42, p = 0.047), triacylglycerols (r = 0.34, p = 0.046), saturated (r = 0.43, p = 0.022), monounsaturated (r = 0.51, p = 0.007), and polyunsaturated fatty acids (r = − 0.53, p = 0.004).</s></p><p><s>In the intervention study, baseline Angiopoietin-like protein 8/betatrophin correlated with age (r = 0.32, p = 0.010) and triacylglycerols (r = 0.30, p = 0.02) and was increased with hepatic steatosis (p = 0.033).</s><s>Weight loss reduced liver fat by 45 % and circulating Angiopoietin-like protein 8/betatrophin by 11 % (288 ± 17 vs.</s><s>258 ± 17 pg/ml; p = 0.015).</s><s>Angiopoietin-like protein 8/betatrophin is related to liver steatosis, while visceral adipose tissue represents an additional site of expression in humans.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>* Equal contribution</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>In a recent animal study, Angiopoietin-like protein 8 (ANGPTL8), also known as betatrophin, human C19ORF80, lipasin, or RIFL was reported to promote pancreatic beta-cell mass proliferation in rodents while ameliorating glucose metabolism <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b1">2]</ref>.</s><s>However, this finding could not be reproduced by others <ref type="bibr" target="#b2">[3]</ref>.</s><s>In humans, most <ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref> but not all <ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b9">10]</ref> clinical studies in type 2 diabetes mellitus (T2D) observed correlations of circulating ANGPTL8/betatrophin with variables of glucose homeostasis.</s><s>Moreover, even diabetic nephropathy and retinopathy have been related to a complex network of involved biomarkers including circulating ANGPTL8/betatrophin <ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref>.</s><s>Otherwise, no relationship of ANGPTL8/betatrophin with C-peptide levels could be established in diabetic patients <ref type="bibr" target="#b13">[14,</ref><ref type="bibr" target="#b14">15]</ref>.</s><s>The latter is supported by experimental data indicating that associations of ANGPTL8/betatrophin and glucose metabolism cannot largely be explained by enhanced insulin secretion <ref type="bibr" target="#b15">[16,</ref><ref type="bibr" target="#b16">17]</ref>.</s><s>Therefore, effects on insulin sensitive tissues may contribute to the observed relationship.</s></p><p><s>Nonalcoholic fatty liver disease (NAFLD) predisposes humans to T2D <ref type="bibr" target="#b17">[18]</ref> as NAFLD is closely related to insulin resistance, resulting in hyperinsulinemia, hyperglycemia and hypertriacylglycerolemia <ref type="bibr" target="#b18">[19,</ref><ref type="bibr" target="#b19">20]</ref>.</s><s>The liver was reported as a major site of ANGPTL8/ betatrophin expression in humans <ref type="bibr" target="#b20">[21]</ref>.</s><s>Moreover, ANGPTL8/betatrophin is associated with dyslipidemia in rodents and humans <ref type="bibr" target="#b2">[3,</ref><ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b8">9]</ref>, particularly being involved in triacylglycerol metabolism <ref type="bibr" target="#b21">[22]</ref>.</s><s>Accordingly, we hypothesized that liver fat and ANGPTL8/betatrophin production could interact locally and thereby show interrelations with insulin resistance and circulating lipid profiles.</s><s>Therefore, in a cross-sectional cohort and an independent intervention study, we tested the hypothesis that hepatic steatosis is related to ANGPTL8/betatrophin in humans, and that liver fat reduction due to hypocaloric dieting reduces circulating ANGPTL8/ betatrophin.</s><s>We, moreover, evaluated whether blood lipids and main fatty acid (FA) species in plasma are associated with ANGPTL8/ betatrophin.</s><s>As adipose tissue (AT) represents an alternative site of ANGPTL8/betatrophin mRNA expression <ref type="bibr" target="#b20">[21]</ref> we finally determined whether in humans, visceral adipose tissue (VAT) and subcutaneous adipose tissue (SCAT) show comparable expression levels of ANGPTL8/betatrophin and how these relate to circulating levels.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Subjects and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study groups and ethics</head><p><s>We investigated subgroups from 2 independent studies.</s><s>The study protocol was approved by the institution's human research committee, respectively.</s><s>Informed consent was obtained from all patients for being included in the study.</s><s>Informed consent was obtained after full explanation of the purpose and nature of all procedures used.</s><s>All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.</s></p><p><s>We included subjects from the cross-sectional INSIGHT (German Clinical Trials-Register: DRKS00005450) study <ref type="bibr" target="#b22">[23]</ref>.</s><s>This group comprised 24 participants characterized by the presence of histologically proven liver steatosis but absence of T2D, and 16 subjects without hepatic steatosis, insulin resistance or T2D.</s><s>We further analyzed 57 participants of the B-SMART (Clinical-Trials.gov</s><s>Identifier: NCT00956566) study.</s><s>The B-SMART study was designed as a prospective, randomized trial to compare weight loss and changes of metabolic and cardiovascular variables with reduced carbohydrate or reduced fat hypocaloric diets <ref type="bibr" target="#b23">[24]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Basic characteristics, clinical chemistry and assays</head><p><s>Medical history and anthropometry were evaluated.</s><s>Oral glucose tolerance testing was performed in B-SMART subjects <ref type="bibr" target="#b23">[24]</ref>.</s><s>Insulin resistance was estimated by the homeostasis model-assessment of insulin resistance (HOMA-IR), blood glucose, insulin, lipids, and inflammatory markers were measured by standard methods in all subjects in certified Clinical Chemistry Laboratories <ref type="bibr" target="#b22">[23,</ref><ref type="bibr" target="#b23">24]</ref>.</s><s>Circulating ANGPTL8/betatrophin was analyzed by enzyme-linked immunosorbent assay (ELISA; Wuhan Eiaab Science, Wuhan, China; E11644h, intra-assay coefficient of variation ≤ 4.8 %, inter-assay coefficient of variation ≤ 7.2 %).</s><s>Circulating adiponectin (ALPCO Immunoassays, Salem, NH, USA; #47-ADPHU-E01) was measured in B-SMART participants.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Sampling of tissue specimen</head><p><s>In INSIGHT subjects, liver specimen were harvested from a healthy liver segment and histopathology was evaluated according to accepted criteria <ref type="bibr" target="#b22">[23]</ref>.</s><s>Liver surgery was indicated for non-malignant or malignant indication.</s><s>Samples of SCAT and VAT were taken by knife extraction in the same surgical setting.</s><s>All samples were immediately flash frozen in liquid nitrogen and stored at − 80 °C until analysis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Lipid analysis</head><p><s>Lipids were extracted from plasma of INSIGHT subjects (n = 27) and analyzed for FA species <ref type="bibr" target="#b24">[25]</ref>.</s><s>FA concentrations are expressed as the percentage of the total area of all FA peaks ( % of total fatty acid methyl esters, FAME).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Oral glucose tolerance test</head><p><s>After an overnight fast, blood samples were obtained in B-SMART subjects at baseline and after oral glucose loading (75 g glucose/500 ml) at 15, 30, 45, 60, 75, 90, and 120 min for analysis of glucose and insulin <ref type="bibr" target="#b23">[24]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Magnetic resonance spectroscopy of the liver</head><p><s>All included B-SMART subjects had completed a magnetic resonance (MR) scan at baseline (n = 57) and after 6 months dietary intervention (n = 52) <ref type="bibr" target="#b23">[24]</ref>.</s><s>Intrahepatic lipid (IHL) content was assessed by 1 H MR spectroscopy of the liver <ref type="bibr" target="#b23">[24]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Real time PCR</head><p><s>ANGPTL8/betatrophin messenger mRNA was analyzed in liver tissue, SCAT and VAT of INSIGHT subjects by means of real-time PCR <ref type="bibr" target="#b25">[26]</ref>.</s><s>Primer sequences used for analysis were as follows: 5′-CT-GTCCCGTAGCACCTTCTG-3′ and 5′-CAGAAGGTGCTACGGGA-CAG-3′ for ANGPTL8/betatrophin; 5′-TGACACTGGCAAAACAATG-CA-3′ and 5′-GGTCCTTTTCACCAGCAAGCT-3′ for hypoxanthine-guanine phosphoribosyltransferase 1 (HPRT1), which was used for normalization.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistics</head><p><s>Data were analyzed with IBM SPSS 22.0 (Chicago, IL, USA).</s><s>Data are given as mean ± SEM if not otherwise stated.</s><s>Logarithmic transformation of data was performed if required.</s><s>Depending on data distribution the following procedures were used: Pearson's or Spearman's rank correlation coefficient, Kruskal-Wallis test with Bonferroni post hoc adjustment for multiple testing, Student's t-test or Mann-Whitney U-test.</s><s>Significance level was defined as 2-sided p &lt; 0.05.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ANGPTL8/betatrophin mRNA expression in INSIGHT subjects</head><p><s>We detected ANGPTL8/betatrophin mRNA in the liver of 97 % of all INSIGHT subjects, in VAT of 92 % and in SCAT of 75 %.</s><s>No association of either SCAT (r = − 0.16, p = 0.41), VAT (r = − 0.27, p = 0.13) or liver (r = − 0.13, p = 0.47) ANGPTL8/betatrophin mRNA with circulating levels was found.</s><s>Otherwise, after adjustment for age circulating ANGPTL8/betatrophin correlated with VAT mRNA (r = − 0.33, p = 0.058) and significantly with combined mRNA levels of liver tissue, VAT and SCAT (r = − 0.36, p = 0.029).</s><s>Moreover, liver mRNA was related to circulating ANGPTL8/betatrophin after adjustment for HOMA-IR (r = − 0.36, p = 0.034).</s><s>Remarkably, in AT we observed significantly higher ANGPTL8/betatrophin mRNA levels in VAT as compared to SCAT (p &lt; 0.001; ▶Fig.</s><s>1), where expression levels were negligible.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Associations of ANGPTL8/betatrophin with NAFLD related variables in INSIGHT</head><p><s>Characteristics of the INSIGHT group are given in ▶ table 1. Circulating ANGPTL8/betatrophin was numerically increased in NAFLD vs. non-NAFLD subjects, but this did not reach statistical significance (p = 0.80; ▶table 1).</s><s>Circulating levels were positively correlated with hepatic steatosis (r = 0.42, p = 0.047; ▶ Fig. <ref type="figure" target="#fig_1">2</ref>), age (r = 0.44, p = 0.008), serum triacylglycerols (r = 0.34, p = 0.046), plasma saturated FA (r = 0.43, p = 0.022; suppl.</s><s>Fig. <ref type="figure" target="#fig_0">1s</ref>) and plasma monounsaturated FA (r = 0.51, p = 0.007; suppl.</s><s>Fig. <ref type="figure" target="#fig_1">2s</ref>).</s><s>By contrast, a negative association of circulating ANGPTL8/betatro-phin and plasma polyunsaturated FA was observed (r = − 0.53, p = 0.004; suppl.</s><s>Fig. <ref type="figure">3s</ref>).</s><s>After adjustment for age circulating ANGPTL8/betatrophin was negatively related to low density lipoprotein (LDL) (r = − 0.35, p = 0.042) and high density lipoprotein (HDL) (r = − 0.37, p = 0.029).</s></p><p><s>Hepatic ANGPTL8/betatrophin mRNA correlated with the NAS (r = 0.36, p = 0.023), hepatic steatosis (r = 0.52, p = 0.009; suppl.</s><s>Fig. <ref type="figure">4s</ref>), hepatocyte ballooning degeneration (r = 0.46, p = 0.003) and HOMA-IR (r = 0.35, p = 0.030).</s><s>Otherwise, no associations were found regarding further variables of glucose metabolism.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Modification of ANGPTL8/betatrophin by long term dietary intervention in B-SMART subjects</head><p><s>Baseline characteristics of B-SMART participants are given in ▶table 2. Baseline analysis of circulating ANGPTL8/betatrophin in the B-SMART cohort revealed a correlation with age (r = 0.32, p = 0.010) and serum triacylglycerols (r = 0.30, p = 0.020; suppl.</s><s>Fig. <ref type="figure">5s</ref>).</s><s>A close to significant correlation was also observed with area under the curve (AUC) insulin during the oral glucose tolerance test (r = 0.25, p = 0.052; suppl.</s><s>Fig. <ref type="figure">6s</ref>).</s><s>With adjustment for age, the correlation with insulin AUC became significant (r = 0.33, p = 0.012), while the correlation with serum triacylglycerols remained unchanged (r = 0.32, p = 0.02).</s><s>When stratified according to IHL content, participants with hepatic steatosis had elevated ANGPTL8/betatrophin compared to participants with normal liver fat content (p = 0.033; ▶ Fig. <ref type="figure">3</ref>).</s><s>With dieting, body weight decreased 6.9 kg ( − 7.4 %) together with reductions in IHL by 45 % and plasma ANGPTL8/betatrophin by 11 % (288 ± 17 vs.</s><s>258 ± 17 pg/ml; p = 0.015; ▶Fig.</s><s>4).</s><s>Circulating ANGPTL8/betatrophin reductions tended to be more pronounced on the reduced fat compared with the reduced carbohydrate diet ( − 37 ± 17 vs.</s><s>− 20 ± 17 pg/ml).</s><s>Endocrine Care</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>Our study indicates that ANGPTL8/betatrophin mRNA is expressed at higher levels in human visceral compared to subcutaneous adi-pose tissue and we expand previous findings by showing correlations of ANGPTL8/betatrophin with main fatty acid species in human plasma.</s><s>We further confirm regulation of ANGPTL8/betatrophin by nutritional interventions, and associations with liver steatosis, age, parameters of insulin resistance and lipid metabolism in 2 independent collectives.</s></p><p><s>A central, yet not fully elucidated aspect is the tissue specific contribution to circulating ANGPTL8/betatrophin levels.</s><s>The mRNA expression of ANGPTL8/betatrophin was reported to be very high in the liver compared to other organs and tissues in humans, while in mice AT was identified as an additional expression site <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b20">21]</ref>.</s><s>In our study, hepatic ANGPTL8/betatrophin mRNA correlated with circulating levels after adjustment for HOMA-IR, supporting the liver as a main contributor.</s><s>However, contrasting with earlier findings <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b20">21]</ref> ANGPTL8/betatrophin mRNA was also abundantly expressed in VAT in our subjects.</s><s>This observation was supported by a correlation of VAT mRNA with age adjusted circulating ANGPTL8/ betatrophin.</s><s>Otherwise, human expression patterns in fat tissues were previously analyzed in commercially available cDNA arrays and characteristics of the donor population remain therefore unreported <ref type="bibr" target="#b20">[21]</ref>.</s><s>Our specimen were harvested intraoperatively under perfused conditions from characterized patients.</s><s>Variable results could therefore be at least partially attributed to potential differences regarding the donor groups.</s><s>We moreover observed ANGPTL8/betatrophin mRNA expression in VAT to be higher com-  pared to SCAT, while previous studies showing lower ANGPTL8/betatrophin mRNA expression in AT did not separately focus on VAT and SCAT <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b20">21]</ref>.</s><s>This further contributes to explain contrasting results.</s><s>Support for our findings comes from a recent study in humans, where the authors also detected ANGPTL8/betatrophin mRNA expression in human SCAT <ref type="bibr" target="#b26">[27]</ref>.</s><s>In accordance with the latter and earlier findings from others <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b26">27,</ref><ref type="bibr" target="#b27">28]</ref> SCAT expression in our study was relatively low.</s><s>Moreover, hypothesizing that previous studies mainly investigated ANGPTL8/betatrophin mRNA expression in SCAT, our data provide evidence for the first time that VAT represents another contributor to circulating ANGPTL8/betatrophin in humans.</s><s>Taken together, the liver and AT could variably conribute to circulating ANGPTL8/betatrophin in humans, whereby age, nutrition and insulin levels could represent main regulating factors <ref type="bibr" target="#b21">[22,</ref><ref type="bibr" target="#b26">27]</ref>.</s><s>Multiple lines of evidence link ANGPTL8/betatrophin to lipid metabolism <ref type="bibr" target="#b21">[22]</ref>.</s><s>Particularly, an important role of ANGPTL8/betatrophin in hepatic very low density lipoproteins (VLDL) production has been proposed <ref type="bibr" target="#b20">[21,</ref><ref type="bibr" target="#b21">22]</ref>.</s><s>In these studies, Angptl8/betatrophin knockout mice showed reduced plasma triacylglycerol levels after refeeding, which was explained by reduced VLDL secretion in line with enhanced lipoprotein lipase activity <ref type="bibr" target="#b28">[29]</ref>.</s><s>Conversely, forced ANGPTL8/betatrophin expression produced hypertriacylglycerolemia <ref type="bibr" target="#b2">[3]</ref>.</s><s>In support of these experimental data we observed significant associations of ANGPTL8/betatrophin with circulating triacylglycerols in 2 independent human collectives.</s><s>We further expand previous findings by suggesting a contrasting relationship with polyunsaturated vs. saturated and monounsaturated FA in plasma.</s><s>This could be of interest since ANGPTL8/betatrophin is known to be nutritionally regulated <ref type="bibr" target="#b3">[4,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b21">22]</ref> whereby our intervention supports the impact of dietary manipulation also in the long term.</s><s>Whether, however, this effect is finally mediated by the observed reduction of liver lipids, a decreased intake in, that is, SFA with a consecutively modified circulating FA profile, a combination of these factors or other yet unknown influences cannot be answered with our current study design.</s><s>Otherwise, our data evolve the hypothesis that different FA species could have varying impact on the regulation of ANGPTL8/betatrophin. Indeed, treatment with polyunsaturated FA represents an established therapeutic approach in reducing elevated plasma triacylglycerols <ref type="bibr" target="#b29">[30]</ref>.</s><s>A potential role of ANGPTL8/betatrophin in that regard remains, however, to be defined.</s><s>Endocrine Care</s></p><p><s>Insulin resistance is known to be related to NAFLD <ref type="bibr" target="#b30">[31,</ref><ref type="bibr" target="#b31">32]</ref>.</s><s>In our study, circulating ANGPTL8/betatrophin correlated with insulin AUC, at least after adjustment for age.</s><s>This correlation disappeared following 45 % liver lipid reduction with concomitant ANGPTL8/betatrophin decrease.</s><s>Furthermore both, circulating and hepatic ANGPTL8/betatrophin correlated significantly with histological proven liver steatosis.</s><s>Moreover, hepatic mRNA expression was related to HOMA-IR, while circulating levels correlated with hepatic mRNA expression after adjustment for HOMA-IR.</s><s>Therefore, our findings suggest that hepatic lipid content could play a role to explain the previously observed association of ANGPTL8/betatrophin with variables of glucose metabolism <ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref>.</s><s>In support of the fact that liver fat is accepted as the most important predictor of human insulin resistance <ref type="bibr" target="#b17">[18]</ref>, significantly elevated circulating ANGPTL8/ betatrophin was recently reported in NAFLD patients, while the observed association was abolished after statistical adjustment for insulin resistance <ref type="bibr" target="#b32">[33]</ref>.</s><s>Thereby it is of major significance that dyslipidemia and particularly hypertriacylglycerolemia are acknowledged features of hepatic insulin resistance <ref type="bibr" target="#b19">[20,</ref><ref type="bibr" target="#b30">31]</ref>.</s><s>Therefore, although we found a significant association of ANGPTL8/betatrophin with hepatic steatosis, we hypothesize that the lack of difference regarding circulating ANGPTL8/betatrophin in in our NAFLD vs. non-NAFLD subjects was rather explained by minor differences between groups in lipid metabolism than by liver steatosis per se.</s></p><p><s>Our study is limited by lack of mechanistic evidence and cannot prove causality.</s><s>Nevertheless, our study showed a robust association between ANGPTL8/betatrophin and hepatic steatosis in 2 independent cohorts using in vivo and ex vivo gold standard methods for liver lipid quantification.</s><s>While we investigated a limited number of human subjects, associations between ANGPTL8/betatrophin and NAFLD were evident in both cohorts.</s></p><p><s>In our study, circulating ANGPTL8/betatrophin was determined using the N-terminus recognizing ELISA and samples in both of our studies were obtained and stored under comparable standard conditions.</s><s>Using the N-terminus recognizing ELISA, Fenzl et al. <ref type="bibr" target="#b9">[10]</ref> vs. Hu et al. <ref type="bibr" target="#b4">[5]</ref> observed about 4-fold higher ANGPTL8/betatrophin levels in healthy controls with comparable BMI.</s><s>In our study, liver ANGPTL8/betatrophin mRNA correlated with the ELISA determined levels, providing evidence for the validity of the measurements.</s><s>However, circulating ANGPTL8/betatrophin levels were about 4-fold higher in INSIGHT compared to B-SMART subjects.</s><s>Otherwise, the detected differences are clearly in line with previous repor ts showing comparable ranges of variabilit y <ref type="bibr" target="#b3">[4,</ref><ref type="bibr" target="#b4">5,</ref><ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b9">10,</ref><ref type="bibr" target="#b32">33]</ref>.</s><s>However, with our current study design, we cannot fully explain the observed differences.</s></p><p><s>Our data suggest the liver and visceral adipose tissue as contributors to circulating ANGPTL8/betatrophin in humans.</s><s>Hepatic lipid accumulation as critical determinant of dyslipidemia and insulin resistance is related to human ANGPTL8/betatrophin.</s><s>Future studies need to account for hepatic lipid content and circulating fatty acid profile as variables to variation in ANGPTL8/betatrophin. study registration: Clinical-Trials.gov</s><s>Identifier: NCT00956566; German Clinical Trials-Register: DRKS00005450.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>▶Fig. 1</head><label>1</label><figDesc><div><p><s>ANGPTL8/betatrophin mRNA in subcutaneous vs. visceral adipose tissue.</s><s>ANGPTL8/betatrophin mRNA was detectable in 92 % of VAT samples in INSIGHT study subjects and 75 % SCAT samples.</s><s>Levels of ANGPTL8/betatrophin mRNA were significantly increased in human VAT compared to SCAT (p &lt; 0.001).</s><s>SCAT: Subcutaneous adipose tissue; VAT: Visceral adipose tissue.</s><s>Boxes span from 25 th -75 th percentile, error bars indicate 10 th and 90 th percentile; * p &lt; 0.05.HMR/2016-08-0275/16.2.2017/MPS von Loeffelholz C. et al.</s><s>Betatrophin in NAFLD … Horm Metab Res 2017; 49: 1-7</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>2</head><label>2</label><figDesc><div><p><s>Data are given as means ± S.E. or absolute numbers, respectively HDL: High-density lipoprotein; HOMA-IR: Homeostasis model of insulin resistance; LDL: Low-density lipoprotein; NAFLD: Nonalcoholic fatty liver disease; NAS: NAFLD activity score ▶Fig.</s><s>Association of circulating ANGPTL8/betatrophin with hepatic steatosis in INSIGHT subjects.</s><s>Scatter plots illustrate correlation of circulating ANGPTL8/betatrophin with logarithmized liver steatosis (r = 0.42, p = 0.047).</s><s>Lines indicate the 95 % confidence intervals.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>▶table 2 3 4</head><label>234</label><figDesc><div><p><s>Baseline characteristics of B-SMART participants<ref type="bibr" target="#b23">[24]</ref>.Data are given as means ± S.E. or absolute numbers, respectively HDL: High-density lipoprotein; HOMA-IR: Homeostasis model of insulin resistance; IHL: Intrahepatic lipids; LDL: Low-density lipoprotein ▶Fig.</s><s>Associations of ANGPTL8/betatrophin with hepatic steatosis in the B-SMART cohort.</s><s>Stratification according to IHL revealed that subjects with hepatic steatosis (20.1 ± 2.5 % IHL, n = 15) had elevated ANGPTL8/betatrophin compared to nonsteatotic (4.0 ± 0.4 % IHL, n = 42) subjects (p = 0.033).</s><s>Data are shown as mean ± SEM; IHL, intrahepatic lipids; * p &lt; 0.05.</s><s>▶Fig.</s><s>Association of ANGPTL8/betatrophin with weight loss in B-SMART.</s><s>After a mean weight loss of 6.9 kg ( = 7.4 % initial body weight) due to dietary intervention accompanied by a 45 % IHL reduction, ANGPTL8/betatrophin decreased by 11 % (p = 0.015).</s><s>Data are shown as mean ± SEM; IHL:Intrahepatic lipids; * p &lt; 0.05.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head></head><label></label><figDesc><div><p><s>[23]acteristics of INSIGHT participants[23].</s></p></div></figDesc><table><row><cell>characteristics</cell><cell>Non NAFLD</cell><cell>NAFLD</cell><cell>p-Value</cell></row><row><cell>n ( % male)</cell><cell>16 (31)</cell><cell>24 (46)</cell><cell>-</cell></row><row><cell>Age (years)</cell><cell>54 ± 4</cell><cell>60 ± 3</cell><cell>0.24</cell></row><row><cell>Body mass index (kg/m²)</cell><cell>23.8 ± 0.9</cell><cell>27.0 ± 1.4</cell><cell>0.075</cell></row><row><cell>Waist circumference (cm)</cell><cell>87.2 ± 3.7</cell><cell>96.3 ± 3.0</cell><cell>0.044</cell></row><row><cell>NAFLD activity score (0-8)</cell><cell>0.2 ± 0.1</cell><cell>2.2 ± 0.2</cell><cell>&lt; 0.001</cell></row><row><cell>Ballooning degeneration (0-2)</cell><cell>0</cell><cell>0.3 ± 0.1</cell><cell>0.28</cell></row><row><cell>Liver inflammation (0-3)</cell><cell>0.2 ± 0.1</cell><cell>0.7 ± 0.2</cell><cell>0.075</cell></row><row><cell>Fibrosis (0-4)</cell><cell>1.1 ± 0.3</cell><cell>1.1 ± 0.3</cell><cell>0.90</cell></row><row><cell>Liver steatosis ( %)</cell><cell>0.4 ± 0.3</cell><cell>20.6 ± 4.0</cell><cell>&lt; 0.001</cell></row><row><cell>Alanine-transaminase (U/l)</cell><cell>41 ± 16</cell><cell>47 ± 8</cell><cell>0.16</cell></row><row><cell>C-reactive protein (mg/dl)</cell><cell>1.2 ± 0.6</cell><cell>2.3 ± 0.8</cell><cell>0.13</cell></row><row><cell>Triacylglycerols (mmol/l)</cell><cell>1.2 ± 0.1</cell><cell>1.3 ± 0.1</cell><cell>0.50</cell></row><row><cell>LDL cholesterol (mmo/l)</cell><cell>3.3 ± 0.3</cell><cell>3.2 ± 0.2</cell><cell>0.90</cell></row><row><cell>HDL cholesterol (mmol/l)</cell><cell>1.3 ± 0.1</cell><cell>1.2 ± 0.1</cell><cell>0.77</cell></row><row><cell>Blood glucose (mmol/l)</cell><cell>4.9 ± 0.2</cell><cell>5.2 ± 0.3</cell><cell>0.27</cell></row><row><cell>HOMA-IR</cell><cell>1.8 ± 0.6</cell><cell>2.6 ± 0.6</cell><cell>0.12</cell></row><row><cell>HbA1c (mmol/mol)</cell><cell>35.2 ± 1.9</cell><cell>36.4 ± 1.4</cell><cell>0.51</cell></row></table><note><p><s>▶table 1</s></p></note></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>We thank A. Borchert, E. Meyer, K. Sprengel and S. Richter for outstanding technical assistance.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Funding: This project was supported by a grant of the German Diabetes Federation (DDG).</s><s>The B-SMART study was supported by the Federal Ministry of Education and Research (BMBF-0313868).</s><s>The work was also supported in part by the German Obesity Network of Competence (Collaborative Project ADIPOSETARGET, 01Gl0830).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflict of Interest</head><p><s>The authors declare that they have no conflict of interest.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Betatrophin: a hormone that controls pancreatic β cell proliferation</title>
		<author>
			<persName><forename type="first">P</forename><surname>Yi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Melton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">153</biblScope>
			<biblScope unit="page" from="747" to="758" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">In vivo targeted delivery of ANGPTL8 gene for beta cell regeneration in rats</title>
		<author>
			<persName><forename type="first">J</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">L</forename><surname>Meng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Clayton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Grayburn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetologia</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="1036" to="1044" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">ANGPTL8/ betatrophin does not control pancreatic beta cell expansion</title>
		<author>
			<persName><forename type="first">V</forename><surname>Gusarova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Alexa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Na</forename><forename type="middle">E</forename><surname>Stevis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Xin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Bonner-Weir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Hobbs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Yancopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">D</forename><surname>Gromada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">159</biblScope>
			<biblScope unit="page" from="691" to="696" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Fu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Berhane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fite</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Seyoum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Abou-Samra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci Rep</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">5013</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Increased circulating levels of betatrophin in newly diagnosed type 2 diabetic patients</title>
		<author>
			<persName><forename type="first">H</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Hong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Qian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Yuan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="2718" to="2722" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Increased circulating betatrophin concentrations in patients with type 2 diabetes</title>
		<author>
			<persName><forename type="first">D</forename><surname>Espes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Martinell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">O</forename><surname>Carlsson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Endocrinol</title>
		<imprint>
			<biblScope unit="page">323407</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes</title>
		<author>
			<persName><forename type="first">J</forename><surname>Gómez-Ambrosi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Pascual</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Catalán</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rodríguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Ramírez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Silva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Gil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Salvador</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Frühbeck</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="2004" to="2009" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Higher plasma betatrophin/ANGPTL8 level in Type 2 Diabetes subjects does not correlate with blood glucose or insulin resistance</title>
		<author>
			<persName><forename type="first">M</forename><surname>Abu-Farha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Abubaker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Al-Khairi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Cherian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Noronha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">B</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Behbehani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Elkum</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci Rep</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">10949</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Circulating betatrophin is elevated in patients with type 1 and type 2 diabetes</title>
		<author>
			<persName><forename type="first">H</forename><surname>Yamada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Saito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Aoki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Asano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yoshida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ikoma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Kusaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Toyoshima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kakei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Ishikawa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocr J</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="417" to="421" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals</title>
		<author>
			<persName><forename type="first">A</forename><surname>Fenzl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Itariu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kosi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fritzer-Szekeres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kautzky-Willer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Stulnig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Kiefer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetologia</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="1204" to="1208" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Serum betatrophin concentrations are significantly increased in overweight but not in obese or type 2 diabetic individuals</title>
		<author>
			<persName><forename type="first">K</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Pan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Bao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Jia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Obesity (Silver Spring)</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="793" to="797" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Serum and plasma levels of vascular endothelial growth factors in relation to quality of glucose control, biomarkers of inflammation, and diabetic nephropathy</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hanefeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Appelt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Engelmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Sandner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Bornstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Ganz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Henkel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Haase</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Birkenfeld</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Horm Metab Res</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="529" to="534" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Positive association between betatrophin and diabetic retinopathy risk in type 2 diabetes patients</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">Y</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">Q</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">J</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">G</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Horm Metab Res</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="169" to="173" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes</title>
		<author>
			<persName><forename type="first">D</forename><surname>Espes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">O</forename><surname>Carlsson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetologia</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="50" to="53" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Lack of associations between betatrophin/ ANGPTL8 level and C-peptide in type 2 diabetic subjects</title>
		<author>
			<persName><forename type="first">M</forename><surname>Abu-Farha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Abubaker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Noronha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Al-Khairi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Cherian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Alarouj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bennakhi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Elkum</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cardiovasc Diabetol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">112</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Betatrophin-promises fading and lessons learned</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Kaestner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Metab</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="932" to="933" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Perspectives on the activities of ANGPTL8/ betatrophin</title>
		<author>
			<persName><forename type="first">P</forename><surname>Yi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Melton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">159</biblScope>
			<biblScope unit="page" from="467" to="468" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Korenblat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Fabbrini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Mohammed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Klein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">134</biblScope>
			<biblScope unit="page" from="1369" to="1375" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">The role of mitochondria in insulin resistance and type 2 diabetes mellitus</title>
		<author>
			<persName><forename type="first">J</forename><surname>Szendroedi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Phielix</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Roden</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Endocrinol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="92" to="103" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Dyslipidemia in patients with nonalcoholic fatty liver disease</title>
		<author>
			<persName><forename type="first">H</forename><surname>Chatrath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Vuppalanchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Chalasani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Semin Liver Dis</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="22" to="29" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels</title>
		<author>
			<persName><forename type="first">R</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem Biophys Res Commun</title>
		<imprint>
			<biblScope unit="volume">424</biblScope>
			<biblScope unit="page" from="786" to="792" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">A dual role of lipasin (betatrophin) in lipid metabolism and glucose homeostasis: consensus and controversy</title>
		<author>
			<persName><forename type="first">R</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Abou-Samra</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cardiovasc Diabetol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">133</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Modulation of Insulin degrading enzyme activity and liver cell proliferation</title>
		<author>
			<persName><forename type="first">C</forename><surname>Pivovarova Von Loeffelholz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Ilkavets</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sticht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Zhuk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Murahovschi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lukowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Döcke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kriebel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>De Las Heras Gala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Malashicheva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kostareva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Lock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Stockmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Grallert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Gretz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dooley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Pfeiffer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Rudovich</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Cycle</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="2293" to="2300" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects</title>
		<author>
			<persName><forename type="first">S</forename><surname>Haufe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Engeli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kast</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Böhnke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Utz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Haas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hermsdorf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mähler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wiesner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Birkenfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Otto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mehling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Luft</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Eckel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Schulz-Menger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Boschmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Jordan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hepatology</title>
		<imprint>
			<biblScope unit="volume">2011</biblScope>
			<biblScope unit="page" from="1504" to="1514" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Fatty acid distribution of cord and maternal blood in human pregnancy: special focus on individual trans fatty acids and conjugated linoleic acids</title>
		<author>
			<persName><forename type="first">U</forename><surname>Enke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jaudszus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Schleussner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Seyfarth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Jahreis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kuhnt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lipids Health Dis</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">247</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease</title>
		<author>
			<persName><forename type="first">S</forename><surname>Döcke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Lock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Birkenfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hoppe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lieske</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rieger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Raschzok</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Sauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Florian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Osterhoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Heller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Herrmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lindenmüller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Horn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">O</forename><surname>Weickert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Neuhaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Stockmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Möhlig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Pfeiffer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Von Loeffelholz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Endocrinol</title>
		<imprint>
			<biblScope unit="volume">169</biblScope>
			<biblScope unit="page" from="547" to="557" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Regulation of Angiopoietin-Like Proteins (ANGPTLs) 3 and 8 by Insulin</title>
		<author>
			<persName><forename type="first">Nidhina</forename><surname>Haridas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Soronen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sädevirta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mysore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Quagliarini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Pasternack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Metso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Perttilä</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Leivonen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Smas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Fischer-Posovszky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Wabitsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ehnholm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ritvos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Jauhiainen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Olkkonen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Yki-Järvinen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="page" from="E1299" to="E1307" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism</title>
		<author>
			<persName><forename type="first">G</forename><surname>Ren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Smas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">303</biblScope>
			<biblScope unit="page" from="E334" to="E351" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Quagliarini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Gusarova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gromada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Valenzuela</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Hobbs</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page" from="16109" to="16114" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Treatment of hypertriglyceridemia: a review of current options</title>
		<author>
			<persName><forename type="first">M</forename><surname>Vrablík</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Češka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Physiol Res</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="S331" to="S340" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Birkenfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">I</forename><surname>Shulman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hepatology</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="713" to="723" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">The metabolic vascular syndrome -guide to an individualized treatment</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hanefeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Pistrosch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Bornstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Birkenfeld</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Rev Endocr Metab Disord</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="5" to="17" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Association between betatrophin/ ANGPTL8 and non-alcoholic fatty liver disease: animal and human studies</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Yoon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Jeon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Cha</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci Rep</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">24013</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
